{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ketamine+0.2+mg%2Fkg&page=2", "query": { "intervention": "Ketamine 0.2 mg/kg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 30, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ketamine+0.2+mg%2Fkg&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ketamine+0.2+mg%2Fkg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T04:06:01.008Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01591382", "title": "Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Hydromorphone PCA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2008-09", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-03-22", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01591382" }, { "nct_id": "NCT01209845", "title": "Ketamine for Low Mood States in the ER", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Depression", "Suicide Ideation" ], "interventions": [ { "name": "ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2010-04", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2020-08-24", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01209845" }, { "nct_id": "NCT03408340", "title": "Paravertebral Nerve Blocks in Neonates", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Congenital Heart Disease" ], "interventions": [ { "name": "Paravertebral Nerve Block", "type": "PROCEDURE" }, { "name": "Standard of Care Anesthesia", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "12 Months", "sex": "ALL", "summary": "Up to 12 Months" }, "enrollment_count": 16, "start_date": "2018-07-18", "completion_date": "2020-07-28", "has_results": true, "last_update_posted_date": "2025-03-24", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03408340" }, { "nct_id": "NCT05444751", "title": "GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lumbar Disc Herniation", "Lumbar Disc Disease", "Lumbar Radiculopathy" ], "interventions": [ { "name": "General anesthetic", "type": "DRUG" }, { "name": "SA + ESP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 142, "start_date": "2022-03-22", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05444751" }, { "nct_id": "NCT04011592", "title": "Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Partum Depression" ], "interventions": [ { "name": "Ketamine 0.5 mg/kg", "type": "DRUG" }, { "name": "Ketamine 0.2 mg/kg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 1, "start_date": "2019-03-04", "completion_date": "2019-09-09", "has_results": true, "last_update_posted_date": "2021-10-19", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04011592" }, { "nct_id": "NCT00595530", "title": "Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Connecticut Children's Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 3, "start_date": "2008-03-04", "completion_date": "2010-02-12", "has_results": true, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 2, "location_summary": "Farmington, Connecticut • Hartford, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00595530" }, { "nct_id": "NCT04199468", "title": "THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabis", "Ketamine" ], "interventions": [ { "name": "Active Delta-9-THC", "type": "DRUG" }, { "name": "Placebo Delta-9-THC", "type": "DRUG" }, { "name": "Active Ketamine", "type": "DRUG" }, { "name": "Placebo Ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 22, "start_date": "2019-09-24", "completion_date": "2022-06-21", "has_results": false, "last_update_posted_date": "2024-03-25", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199468" }, { "nct_id": "NCT01920555", "title": "Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Treatment Resistant Depression" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 99, "start_date": "2014-12", "completion_date": "2017-02", "has_results": true, "last_update_posted_date": "2018-06-19", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 6, "location_summary": "Palo Alto, California • New Haven, Connecticut • Boston, Massachusetts + 3 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01920555" }, { "nct_id": "NCT03613792", "title": "Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bronchoscopy" ], "interventions": [ { "name": "Remifentanil", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 0, "start_date": "2023-09", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03613792" }, { "nct_id": "NCT04005209", "title": "Ketamine Infusion for Sickle Cell Pain Crisis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anemia; Sickle-Cell, With Crisis", "Acute Pain" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Pain management", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2022-01", "completion_date": "2022-11", "has_results": false, "last_update_posted_date": "2022-01-14", "last_synced_at": "2026-10-05T04:06:01.008Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04005209" } ] }